Apoptosis and Cancer || The ChemoFx® Assay: An Ex Vivo Chemosensitivity and Resistance Assay for Predicting Patient Response to Cancer Chemotherapy

Low drug resistance to both platinum and

Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer

✍ Koji Matsuo; Virginia K. Bond; Michele L. Eno; Dwight D. Im; Neil B. Rosenshein 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract The objective of this study was to evaluate the role of an __in vitro__ drug resistance assay to platinum and taxane in the management of advanced epithelial ovarian, fallopian and primary peritoneal cancer. All patients with FIGO Stage IIIc and IV who received postoperative chemotherap